The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment

A comparison with tianeptine

Nesha S. Burghardt, Gregory M. Sullivan, Bruce S. McEwen, Jack M. Gorman, Joseph Ledoux

Research output: Contribution to journalArticle

Abstract

Background Selective serotonin reuptake inhibitors (SSRIs) are efficacious in the treatment of a variety of fear or anxiety disorders. Although they inhibit the reuptake of serotonin within hours of administration, therapeutic improvement only occurs after several weeks. In this study, we used fear conditioning to begin to understand how acute and chronic SSRI treatment might differentially affect well-characterized fear circuits. Methods We evaluated the effects of acute and chronic treatment with the SSRI citalopram on the acquisition of auditory fear conditioning. To further understand the role of serotonin in modulating fear circuits, we compared these effects with those of acute and chronic administration of the antidepressant tianeptine, a purported serotonin reuptake enhancer. Results We found that acute administration of the SSRI citalopram enhanced acquisition, whereas chronic treatment reduced the acquisition of auditory fear conditioning. In comparison, treatment with tianeptine had no effect acutely but also reduced the acquisition of tone conditioning when administered chronically. Conclusions Our findings with citalopram are consistent with the clinical effects of SSRI treatment seen in patients with anxiety disorders, in which anxiety is often increased during early stages of treatment and decreased after several weeks of treatment. The findings also indicate that auditory fear conditioning can be a useful tool in understanding differences in the effects of short-term and long-term antidepressant treatment with serotonergic medications.

Original languageEnglish (US)
Pages (from-to)1171-1178
Number of pages8
JournalBiological Psychiatry
Volume55
Issue number12
DOIs
StatePublished - Jun 15 2004

Fingerprint

tianeptine
Citalopram
Serotonin Uptake Inhibitors
Fear
Therapeutics
Serotonin
Anxiety Disorders
Antidepressive Agents

Keywords

  • amygdala
  • anxiety
  • citalopram
  • Fear conditioning
  • serotonin
  • tianeptine

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment : A comparison with tianeptine. / Burghardt, Nesha S.; Sullivan, Gregory M.; McEwen, Bruce S.; Gorman, Jack M.; Ledoux, Joseph.

In: Biological Psychiatry, Vol. 55, No. 12, 15.06.2004, p. 1171-1178.

Research output: Contribution to journalArticle

@article{37695fe2e6904d2da3a34415bd08c1fc,
title = "The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: A comparison with tianeptine",
abstract = "Background Selective serotonin reuptake inhibitors (SSRIs) are efficacious in the treatment of a variety of fear or anxiety disorders. Although they inhibit the reuptake of serotonin within hours of administration, therapeutic improvement only occurs after several weeks. In this study, we used fear conditioning to begin to understand how acute and chronic SSRI treatment might differentially affect well-characterized fear circuits. Methods We evaluated the effects of acute and chronic treatment with the SSRI citalopram on the acquisition of auditory fear conditioning. To further understand the role of serotonin in modulating fear circuits, we compared these effects with those of acute and chronic administration of the antidepressant tianeptine, a purported serotonin reuptake enhancer. Results We found that acute administration of the SSRI citalopram enhanced acquisition, whereas chronic treatment reduced the acquisition of auditory fear conditioning. In comparison, treatment with tianeptine had no effect acutely but also reduced the acquisition of tone conditioning when administered chronically. Conclusions Our findings with citalopram are consistent with the clinical effects of SSRI treatment seen in patients with anxiety disorders, in which anxiety is often increased during early stages of treatment and decreased after several weeks of treatment. The findings also indicate that auditory fear conditioning can be a useful tool in understanding differences in the effects of short-term and long-term antidepressant treatment with serotonergic medications.",
keywords = "amygdala, anxiety, citalopram, Fear conditioning, serotonin, tianeptine",
author = "Burghardt, {Nesha S.} and Sullivan, {Gregory M.} and McEwen, {Bruce S.} and Gorman, {Jack M.} and Joseph Ledoux",
year = "2004",
month = "6",
day = "15",
doi = "10.1016/j.biopsych.2004.02.029",
language = "English (US)",
volume = "55",
pages = "1171--1178",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment

T2 - A comparison with tianeptine

AU - Burghardt, Nesha S.

AU - Sullivan, Gregory M.

AU - McEwen, Bruce S.

AU - Gorman, Jack M.

AU - Ledoux, Joseph

PY - 2004/6/15

Y1 - 2004/6/15

N2 - Background Selective serotonin reuptake inhibitors (SSRIs) are efficacious in the treatment of a variety of fear or anxiety disorders. Although they inhibit the reuptake of serotonin within hours of administration, therapeutic improvement only occurs after several weeks. In this study, we used fear conditioning to begin to understand how acute and chronic SSRI treatment might differentially affect well-characterized fear circuits. Methods We evaluated the effects of acute and chronic treatment with the SSRI citalopram on the acquisition of auditory fear conditioning. To further understand the role of serotonin in modulating fear circuits, we compared these effects with those of acute and chronic administration of the antidepressant tianeptine, a purported serotonin reuptake enhancer. Results We found that acute administration of the SSRI citalopram enhanced acquisition, whereas chronic treatment reduced the acquisition of auditory fear conditioning. In comparison, treatment with tianeptine had no effect acutely but also reduced the acquisition of tone conditioning when administered chronically. Conclusions Our findings with citalopram are consistent with the clinical effects of SSRI treatment seen in patients with anxiety disorders, in which anxiety is often increased during early stages of treatment and decreased after several weeks of treatment. The findings also indicate that auditory fear conditioning can be a useful tool in understanding differences in the effects of short-term and long-term antidepressant treatment with serotonergic medications.

AB - Background Selective serotonin reuptake inhibitors (SSRIs) are efficacious in the treatment of a variety of fear or anxiety disorders. Although they inhibit the reuptake of serotonin within hours of administration, therapeutic improvement only occurs after several weeks. In this study, we used fear conditioning to begin to understand how acute and chronic SSRI treatment might differentially affect well-characterized fear circuits. Methods We evaluated the effects of acute and chronic treatment with the SSRI citalopram on the acquisition of auditory fear conditioning. To further understand the role of serotonin in modulating fear circuits, we compared these effects with those of acute and chronic administration of the antidepressant tianeptine, a purported serotonin reuptake enhancer. Results We found that acute administration of the SSRI citalopram enhanced acquisition, whereas chronic treatment reduced the acquisition of auditory fear conditioning. In comparison, treatment with tianeptine had no effect acutely but also reduced the acquisition of tone conditioning when administered chronically. Conclusions Our findings with citalopram are consistent with the clinical effects of SSRI treatment seen in patients with anxiety disorders, in which anxiety is often increased during early stages of treatment and decreased after several weeks of treatment. The findings also indicate that auditory fear conditioning can be a useful tool in understanding differences in the effects of short-term and long-term antidepressant treatment with serotonergic medications.

KW - amygdala

KW - anxiety

KW - citalopram

KW - Fear conditioning

KW - serotonin

KW - tianeptine

UR - http://www.scopus.com/inward/record.url?scp=2942590540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942590540&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2004.02.029

DO - 10.1016/j.biopsych.2004.02.029

M3 - Article

VL - 55

SP - 1171

EP - 1178

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 12

ER -